Summary
Orthostatic hypotension occurs in 10 to 30% of the elderly. In several studies it has been linked to recurrent falls and syncope. Generally, it has multiple causes, of which autonomic dysfunction plays an important role in elderly people. Very often orthostatic hypotension is induced by the use of drugs. In other cases, it is already present subclinically, and is worsened by the use of drugs to become symptomatic.
For most drugs, changing pharmacokinetics result in a delayed elimination and/or in a greater bioavailability in the elderly. This results in a more pronounced effect for drugs with a desired hypotensive action [e.g. diuretics, calcium channel blockers, β-blockers, angiotensin converting enzyme (ACE) inhibitors]. For those drugs in which hypotension is a known but unwanted adverse effect (e.g. nitrates, anti-Parkinsonian drugs, antidepressants, antipsychotics), responses will be greater in the elderly and orthostatic hypotension will occur more frequently. For elderly people, doses have to be reduced and/or the dose intervals prolonged in order to avoid such adverse reactions.
Similar content being viewed by others
References
Busby WJ, Campbell AJ, Robertson MC. Is low blood pressure in elderly people just a consequence of heart disease and frailty? Age Ageing 1994; 23: 69–74
Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23: 255–9
Streeten DHP. Orthostatic disorders of the circulation. New York: Plenum, 1987
Palmer KT. Studies into postural hypotension in elderly patients. NZ Med J 1983; 96: 43–5
Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA 1987; 258: 1511–4
Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989; 44: M112–M117
Robbins AS, Rubenstein LZ, Josephson KR, et al. Predictors of falls among elderly people: results of two population-based studies. Arch Intern Med 1989; 149: 1628–33
Si M, Rodstein M, Neufeld RR, et al. Orthostatic change in blood pressure in non-demented, ambulatory nursing home patients. Arch Gerontol Geriatr 1992; 14: 123–9
Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults: the cardiovascular health study. Hypertension 1992; 19: 508–19
Applegate WB, Davis BR, Black HR, et al. Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc 1991; 39: 1057–64
Patel A, Maloney A, Damato AN. On the frequency and reproducibility of orthostatic blood pressure changes in healthy community-dwelling elderly during 60-degree head-up tilt. Am Heart J 1993; 126: 184–8
Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989; 320: 1055–9
Granek E, Baker SP, Abbey H, et al. Medications and diagnoses in relation to falls in a long-term care facility. J Am Geriatr Soc 1987; 35: 503–11
Blake AJ, Morgan K, Bendall MJ, et al. Falls by elderly people at home: prevalence and associated factors. Age Ageing 1988; 17: 365–72
Lipsitz LA, Jonsson PV, Kelley MM, et al. Causes and correlates of recurrent falls in ambulatory frail elderly. J Gerontol 1991; 46: M114–M122
Burke V, Beilin LJ, German R, et al. Postural fall in blood pressure in the elderly in relation to drug treatment and other lifestyle factors. Q J Med 1992; 84: 583–91
Mclntosh S, Da Costa D, Kenny RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a ‘syncope’ clinic. Age Ageing 1993; 22: 53–8
Robertson D. Mechanisms of orthostatic hypotension. Curr Opin Cardiol 1993; 8: 737–45
Lipsitz LA, Nyquist RP, Wei JY, et al. Post-prandial reduction in blood pressure in the elderly. N Engl J Med 1983; 309: 81–3
Lipsitz LA, Pluchino FC, Wei JY, et al. Cardiovascular and norepinephrine response following meal consumption in elderly persons with post-prandial hypotension and syncope. Am J Cardiol 1986; 58: 810–5
Jansen RWMM, Hoefnagels WHL. Hormonal mechanisms of postprandial hypotension. J Am Geriatr Soc 1991; 39: 1201–7
Wollner L, McCarthy ST, Soper NDW, et al. Failure of cerebral autoregulation as a cause of brain dysfunction in the elderly. BMJ 1979; 1: 1117–8
Ward C, Kenny RA. The reproducibility of orthostatic hypotension in the elderly presenting with postural symptoms [abstract]. Age Ageing 1994; 23 Suppl. 2: P19
Tjoa HI, Kaplan NM. Treatment of hypertension in the elderly. JAMA 1990; 264: 1015–8
Fotherby MD, Potter JF. Orthostatic hypotension and anti-hypertensive therapy in the elderly [abstract]. Age Ageing 1994; 23 Suppl. 2: P13
Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9; 73–80
MacLennan WJ. Diuretics in the elderly: how safe? BMJ 1988; 296: 1551–2
Shannon RP, Wei JY, Rosa RM, et al. The effect of age and sodium depletion on cardiovascular response to orthostasis. Hypertension 1986; 5: 438–43
Slater SD, McKillop G, Canning G. Diuretics in the elderly. BMJ 1988; 297: 132
Canning G, McKillop G, Slater SD. Dilutional hyponatraemia due to hydrochlorothiazide plus amiloride (Moduretic): not to be mistaken for the syndrome of inappropriate secretion of antidiuretic hormone. Br J Clin Pract 1988; 42: 41–2
Levine SD. Diuretics. Med Clin North Am 1989; 73: 271–82
Andreasen F, Hansen V, Husted SE, et al. The influence of age on renal and extrarenal effects of frusemide. Br J Clin Pharmacol 1984; 18: 65–74
McAllister RG, Hamann SR, Blouin RA. Pharmacokinetics of calcium-entry blockers. Am J Cardiol 1985; 55 (Suppl.): 30B–40B
Robertson DRC, Waller DG, Renwick AG, et al. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 1988; 25: 297–305
Schwartz JB, Abernethy DR. Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. Am J Cardiol 1987; 59: 1111–7
Abernethy DR, Schwartz JB, Todd EL, et al. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Ann Intern Med 1986; 105: 329–36
Elliott HL. Calcium antagonists in the treatment of hypertension and angina pectoris in the elderly. J Cardiovasc Pharmacol 1989; 13 Suppl. 4: S12–S16
Wei JY. Use of calcium entry blockers in elderly patients. Circulation 1989; 80 Suppl. IV: IV171–IV177
Pearigen P, Benowitz N. Poisoning due to calcium antagonists. Drug Safety 1991; 6: 408–30
Litovitz TL, Holm KC, Clancy C, et al. 1992 annual report of the American Association of Poison Control Centres Toxic Exposure Surveillance System. Am J Emerg Med 1993; 11: 494–555
Xiao RP, Lakatta EG. Deterioration of beta-adrenergic modulation of cardiovascular function with aging. Ann NY Acad Sci 1992; 673: 293–310
Gottlieb SS. Beta-blockers for heart failure: where are we now? Curr Opin Cardiol 1994; 9: 295–300
Abernethy DR, Schwartz JB, Plachetka JR, et al. Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension. Am J Cardiol 1987; 60: 697–702
De Bock V, Mets T, Romagnoli M, et al. Captopril treatment of chronic heart failure in the very old. J Gerontol 1994; 49: M148–M152
Mets T, De Bock V, Praet JP. First-dose hypotension, ACE inhibitors, and heart failure in the elderly. Lancet 1992; 339: 1487
MacFadyen RJ, Lees KR, Reid JL. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J 1991; 66: 206–11
Cleland JGF, Dargie HJ, McAlpine H, et al. Severe hypotension after first dose of enalapril in heart failure. Br Med J 1985; 291: 1309–12
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
Elseviers MM, Verpooten GA, De Broe ME, et al. Interpretation of creatinine clearance. Lancet 1987, 1: 457
Resplandy G, Genissel P. Pharmacokinetics of perindopril in high-risk populations. J Cardiovasc Pharmacol 1991; 18 Suppl.7: S9–S18
Studer JA, Piepho RW. Antihypertensive therapy in the geriatric patient, II: a review of the alpha1-adrenergic blocking agents. J Clin Pharmacol 1993; 33: 2–13
Klein C, Gerber JG, Payne NA, et al. The effect of age on the sensitivity of the alpha1-adrenoceptor to phenylephrine and prazosin. Clin Pharmacol Ther 1990; 47: 535–9
Alpert JS. Nitrate therapy in the elderly. Am J Cardiol 1990; 65: 23J-27J
Kelly JG, OMalley K. Nitrates in the elderly. Pharmacological considerations. Drugs Aging 1992; 2: 14–9
Eicher HG, Hiremath A, Katzir D, et al. Absence of age-related changes in venous responsiveness to nitroglycerin in vivo in humans. Clin Pharmacol Ther 1987; 42: 521–4
Marchionni N, Schneeweiss A, DiBari M, et al. Age-related hemodynamic effects of intravenous nitroglycerin for acute myocardial infarction and left ventricular failure. Am J Cardiol 1988;61: 81E-83E
Shafer N. Hypotension due to nitroglycerin combined with alcohol [letter]. N Engl J Med 1965; 273: 1169
Robertson DRC, George CF. Drug therapy for Parkinsons disease in the elderly. Br Med Bull 1990; 46: 124–46
Evans MA, Triggs EJ, Broe GA, et al. Systemic availability of orally administered levodopa in the elderly Parkinsonian patient. Eur J Clin Pharmacol 1980; 17: 215–21
Robertson DRC, Wood ND, Everest H, et al. The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Br J Clin Pharmacol 1989; 28: 61–9
Bowes SG, Clark PK, Leeman AL, et al. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. Br J Clin Pharmacol 1990; 30: 13–24
Blazer D. Depression in the elderly. N Engl J Med 1989; 320: 164–6
Roose SP, Glassman AH. Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. J Clin Psychiatry 1989; 50 (Suppl.): 1–18
Glassman AH, Preudhomme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993; 54 (Suppl.): 16–22
Kitanaka I, Ross RJ, Cutler NR, et al. Altered hydroxydesipramine concentrations in elderly depressed patients. Clin Pharmacol Ther 1982; 31: 51–5
Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 1985; 232: 183–8
Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993; 94 Suppl. 5A: 2S–12S
Preskorn S, Burke M. Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiatry 1992; 53 Suppl.: 1–14
Doogan DP, Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry 1988; 49 (Suppl.): 46–51
Rudorfer MV, Potter WZ. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the ‘newer’ versus the ‘older’ drugs. Drugs 1989; 37: 713–38
Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiatry 1992; 53 (Suppl.): 7–12
Blumenthal MD, Davie JW. Dizziness and falling in elderly psychiatric outpatients. Am J Psychiatry 1980; 137: 203–6
Rosen J, Bohon S, Gershon S. Antipsychotics in the elderly. Acta Psychiatr Scand 1990; 82 Suppl. 358: 170–5
Steinhart MJ. The use of haloperidol in geriatric patients with organic mental disorder. Curr Ther Res 1983; 33: 132–43
Lipowski ZJ. Delirium in the elderly patient. N Engl J Med 1989; 320: 578–82
Clark ANG. Postural hypotension in the elderly [editorial]. BMJ 1987; 295: 683
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mets, T.F. Drug-Induced Orthostatic Hypotension in Older Patients. Drugs & Aging 6, 219–228 (1995). https://doi.org/10.2165/00002512-199506030-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199506030-00005